Gabapentinoids are associated with an increased risk for drug poisoning, particularly in the short-term after initiation, according to a study published online ...

"Recent history tells us if she's confirmed, she will be under real threat to follow ideology over evidence in what is a ...

Treatment with satralizumab reduced the risk of new MOGAD relapse by 68% vs placebo. Positive results were announced from a phase 3 trial evaluating satralizumab for the treatment of myelin ...

No increase seen in incidence of major bleeding, adverse events, or serious adverse events compared with placebo.

Older adults with adenoma at prior colonoscopy more likely to experience CRC but risk exceeded by competing risks for non-CRC death.

Supported by the phase 3 ALLEGORY trial, the application moves obinutuzumab closer to becoming a new standard for patients with active, autoantibody-positive SLE.

Treatment with daraxonrasib significantly improves progression free survival and overall survival in patients with previously treated metastatic pancreatic ductal adenocarcinoma. Topline results were ...

The US Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies. Peptides are small chains of amino acids ...

Phase 3 KEYNOTE-B15 data demonstrate that perioperative enfortumab vedotin and pembrolizumab significantly improve EFS, OS, and pCR compared with standard chemotherapy.

Psychedelic drugs could soon play a larger role in mental health care. Over the weekend, President Donald Trump signed an executive order aimed at boosting fede ...

Human-generated notes received higher overall modified Physician Documentation Quality Instrument scores than AI-generated notes across all 5 clinical cases. HealthDay News — Notes generated by ...

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.